Welcome

About Pharma IPR USA 2019

Intellectual Property (IP) is the backbone to ensure development of new treatments and cures. IP is extremely vital to improvise patient care, spurring economic growth and intensifying the innovation economy. In order to motivate researchers to explore new areas of medical innovation, modern IP systems and strong protections are crucial. The US pharmaceutical & biopharmaceutical industry drives the nation’s Research and Development (R&D) economy, thereby keeping the country at the forefront of advanced technology development. The pharma and Biopharma industry hence is a key generator of new IP’s across the globe read more...


Key Topics

 

Legal Perspective on Paragraph IV Proceedings
FDA Drivers for ANDA Filing and Litigation
Industry Insights on Hatch-Waxman and Paragraph IV Litigations
Section 101: Interplay between Patent Law and Reproducibility
Victory without Trial: Rule 12(b) and 12(c) Motions for Judgment on the Pleadings
Biopharma Litigation Highlight: Instantaneous Action Plans for Innovators and Biosimilars to Prepare for the Future Battles

Who Should Attend?



Industries/Categories

Biopharma
Pharmaceuticals


Designation

VP Director Head Senior Manager Managers General Manager Executives In – house Counsels


Department

IPR IP Cell Patents Legal Department

Event Objectives




Case studies and practical sessions on different aspects of Intellectual Property Rights in Pharma.


Case studies and practical sessions on different aspects of Intellectual Property Rights in Pharma.


Enhancing your skills to ensure faster approval of patents for early entry in the newer and emerging markets.


Enhancing your skills to ensure faster approval of patents for early entry in the newer and emerging markets.


Understanding the recent developments on Hatch-Waxman, Paragraph IV and BPCIA.


Understanding the recent developments on Hatch-Waxman, Paragraph IV and BPCIA.


International experts from renowned law firms.


International experts from renowned law firms.

Gold Partners

 

Silver Partners

 

Lanyard Partners

 

Supported By

 

Glimpses of Pharma IPR India 2019

 

 

View Image Gallery